110 related articles for article (PubMed ID: 3673583)
1. Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone.
Frimodt-Møller N; Bentzon MW; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):261-7. PubMed ID: 3673583
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
[TBL] [Abstract][Full Text] [Related]
3. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Goldstein FW
Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
[TBL] [Abstract][Full Text] [Related]
4. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Williams-Bouyer N; Hernandez A; Reisner BS
J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
[TBL] [Abstract][Full Text] [Related]
5. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
7. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins.
Frimodt-Møller N; Bentzon MW; Thomsen VF
J Infect Dis; 1986 Sep; 154(3):511-7. PubMed ID: 3734494
[TBL] [Abstract][Full Text] [Related]
8. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
[TBL] [Abstract][Full Text] [Related]
13. Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Karlowsky JA; Jones ME
J Antimicrob Chemother; 2003 Feb; 51(2):467-8. PubMed ID: 12562727
[No Abstract] [Full Text] [Related]
14. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
[TBL] [Abstract][Full Text] [Related]
15. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
McCracken GH; Nelson JD; Grimm L
Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
[TBL] [Abstract][Full Text] [Related]
17. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.
Unowsky J; Sattler J; Patel IH
Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404
[TBL] [Abstract][Full Text] [Related]
18. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
19. Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
Barry AL; Fuchs PC
J Clin Microbiol; 1996 Oct; 34(10):2609-12. PubMed ID: 8880533
[TBL] [Abstract][Full Text] [Related]
20. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Pérez-Trallero E; Alkorta M; Giménez MJ; Vicente D; Aguilar L
J Chemother; 2001 Apr; 13(2):118-25. PubMed ID: 11330357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
